with AI, anticipating the patient's care pathway

Using AI to anticipate the patient's care pathway

March 8, 2026

news

By Arnaud Devillard THE Subscribers

Inria and Doctolib have forged an unprecedented partnership in its scope, focused on decision support and risk prediction for the patient.

The report highlights areas that require significant investment
Read moreThe report highlights areas that require significant investment

Medicine and AI

Can-genetically-modified-broccoli-prevent-cancer?
Read moreCan genetically modified broccoli prevent cancer?

The algorithm would identify risks based on the patient's history in order to intervene in a personalized manner.

Pixabay

This article is taken from the monthly magazine Sciences et Avenir n°949, dated March 2026.

Transparency. Explainability. Reliability. These concepts are repeated like a mantra in the field of artificial intelligence (AI) based on data learning. But they become imperative in the case of medical applications of this AI. This is precisely the aim of the four-year research partnership established between Inria (the French National Institute for Research in Digital Science and Technology) and Doctolib, announced at the end of November 2025.

Medicine Inria Doctolib

“
»
en_USEnglish
fr_FRFrench en_USEnglish